Perampanel

Perampanel

SCHEMBL2868533

N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O.O=S(=O)(O)O

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GRIA1GRIA2GRIA3GRIA4

The experimentally established mechanism targets of Perampanel. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GRIA1 known ✓ P42261 1/20 0.90
GRIA3 known ✓ P42263 1/20 0.90
PDE4D Q08499 1/20 0.90
GRM5 P41594 5/20 0.39
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
MKNK2 Q9HBH9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perampanel SCHEMBL2859211 0.96 GRIA1 (0.86) GRIA1GRIA3PDE4DGRM5MEN1
Perampanel SCHEMBL29718723 0.95 GRIA1 (1.00) GRIA1GRIA3PDE4DGRM5MEN1
Perampanel SCHEMBL29354621 0.95 GRIA1 (1.00) GRIA1GRIA3PDE4DGRM5MEN1
Perampanel SCHEMBL194370 0.95 GRIA1 (1.00) GRIA1GRIA3PDE4DGRM5MEN1
Perampanel SCHEMBL4214584 0.95 GRIA1 (1.00) GRIA1GRIA3PDE4DGRM5MEN1
Perampanel SCHEMBL31069847 0.95 GRIA1 (1.00) GRIA1GRIA3PDE4DGRM5MEN1
Perampanel SCHEMBL2857277 0.95 GRIA1 (1.00) GRIA1GRIA3PDE4DGRM5MEN1
Perampanel SCHEMBL2864324 0.94 GRIA1 (0.83) GRIA1GRIA3PDE4DGRM5MEN1
Perampanel SCHEMBL29363161 0.94 GRIA1 (0.98) GRIA1GRIA3PDE4DGRM5MEN1
Perampanel SCHEMBL2866904 0.94 GRIA1 (0.98) GRIA1GRIA3PDE4DGRM5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718807-B2 Salt of 1,2-dihydropyridine compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-05-18 US claimed
US-20090054654-A1 SALT OF 1,2-DIHYDROPYRIDINE COMPOUND CATALYST PHARMACEUTICALS, INC. 2009-02-26 US claimed
US-7718807-B2 Salt of 1,2-dihydropyridine compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-05-18 US disclosed
US-20090054654-A1 SALT OF 1,2-DIHYDROPYRIDINE COMPOUND CATALYST PHARMACEUTICALS, INC. 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054654-A1 SALT OF 1,2-DIHYDROPYRIDINE COMPOUND SDHA, FH, SDHB GRIA1 1884/4885GRIA3 3682/4885PDE4D 4447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.